Effect of diabetic retinopathy on corneal endothelial parameters: An analytical cross- sectional study

DOI: https://doi.org/10.21203/rs.3.rs-1687907/v1

Abstract

Background: To investigate the possible effect of different types of diabetic retinopathy (DR) on corneal endothelium cells in type 2 diabetes mellitus patients.

Methods: In this descriptive-analytical cross-sectional study, corneal endothelium parameters including endothelial cell density (ECD), average cell size (AVG), coefficient of variation in cell size (CV), and hexagonality (Hex) were evaluated by non-contact specular microscopy.

Results: One hundred and thirty-four eyes of 134 diabetic patients including 77 females (57.5%) with a mean age of 61.03 ± 8.08 years were enrolled. The overall corneal parameters in diabetic patients with and without retinopathy were not significantly different (P>0.05). There is a significant relationship between CV and the duration of the disease with age variable control (B= 0.369, p-value <0.001)

Conclusions: In type-2 DM patients without and with DR, corneal endothelial parameters were not a statistically significant difference. There is a significant relationship between CV and the duration of the disease with age variable control.

Introduction:

The morphological and functional integrity of the endothelial layer of the cornea is a critical factor for the maintenance of corneal clarity. Impairment in morphological or functional of the corneal endothelial layer is associated with increased risk of corneal decompensation due to susceptibility of the cornea to the recurrent corneal erosions, superficial keratitis, punctate epithelial keratopathy, persistent epithelial defects, recurrent ulceration following trauma or surgical insult (13).

Although diabetic retinopathy (DR) is one of the most important causes of blindness all over the world (4, 5), diabetes mellitus (DM) also affect the anterior segment element including corneal endothelium (6, 7). DM can alter cell morphology, cell density, ultrastructure, barrier function, and finally the outcome of any intraocular surgery (8, 9).

Currently, there is inconsistent evidence of whether DR and their severity may affect corneal endothelial indexes or not (1012). There are limited studies on the association of the severity of DR and corneal endothelium parameters (11). This discrepancy may be related to type, severity, and duration of diabetes or type and severity of DR. The clinical importance of corneal endothelial indexes is related to important factors for the prediction of anterior segment surgery including cataract surgery outcomes and corneal transplant outcomes (8, 9).

On one hand, DM causes structural and functional impairments of the corneal endothelium (9, 13), and on the other hand prevalence of anterior segment surgery including cataract surgery is high in these patients; so it seems pre-operative corneal assessment, in the diabetic population, is an important and rational evaluation.

This study aimed to investigate the effects of the DR and their severity and related on the findings of specular microscopy in diabetic patients without and with different DR.

Material And Methods:

Study design and setting

This study is a descriptive-analytical cross-sectional study of the effect of DM and DR on corneal endothelial parameters. It was performed in the eye Feiz Hospital affiliated with the Isfahan University of Medical Sciences in Isfahan between April 2019 and June 2020. The study was conducted by the provisions of the Helsinki Declaration. This study was performed based on ethical code obtained from Isfahan University of Medical Sciences with the number IR.MUI.MED.REC.1399.709. Written consent was obtained from all participants in the study before enrolling in the study.

Participants

Participants in the study included men and women with the ages of over 40 years who had a definite diagnosis of type 2 DM. Exclusion criteria included conditions affecting the health of corneal endothelium like the history of injection of intraocular anti-vascular endothelial growth factor medications in the last 3 months, history of intraocular surgery/laser, corneal dystrophy, history of ocular trauma, active or passive ocular inflammation, active or passive ocular infection, any history of glaucoma in the patient, pregnancy, and lactation.

Ophthalmological examinations

Slit-lamp biomicroscopy was performed to evaluate the corneal and lens condition. Besides, a fundus exam by indirect ophthalmoscope was performed by an expert ophthalmologist. The patients were categorized into five subgroups based on the type of retinal involvement included: 1- diabetic patients without retinal involvement, 2- diabetic patients with mild and moderate non-proliferative DR (NPDR), 3- diabetic patients with severe NPDR, 4- diabetic patients with mild proliferative DR (PDR), 5- diabetic patients with high-risk PDR.

Early Treatment Diabetic Retinopathy Study (ETDRS) criteria were used as standardized guidelines for the interpretation of the various forms of DR (14).

In addition, patients were assessed by Non-contact specular microscopy (Tomey Corporation Inc, Nagoya, Japan) to evaluate the corneal endothelial cells.

Corneal endothelial cells parameters included endothelial cell density (ECD), average cell size (AVG), coefficient of variation in cell size (CV), and hexagonality (Hex). CV less than 40, Hex above 60, and cell density in the range of 1500–2500 were considered normal (8, 10).

Statistical analysis

Data were analyzed using SPSS version 2020 (SPSS inc. Chicago IL). The results were expressed as mean ± standard deviation (SD) or as medians with ranges. Independent samples t-test was applied to compare the means of continuous variables. For continuous variables with skewed distributions, the Mann–Whitney U test was applied. Statistically significant differences were analyzed by the chi-square test for categorical variables. The differences among 3 or more groups were analyzed by one-way ANOVA. Also, the partial correlation coefficient that controlled for age was used to evaluate the correlation between the duration of the disease and corneal endothelial parameters. Patients were divided into different subgroups based on the existence and severity of DR and the condition of patients' corneal endothelial cells. A value of P ≤ 0.05 was considered statistically significant.

Results:

One hundred and thirty-four eyes of 134 diabetic patients, 40 without DR, and 94 with different degrees of DR were enrolled. The mean age of the patients was 61.03 ± 8.08 years and there were 77 females (57.5%). The median duration of diabetic disease was 10 [7,34] years. Table 1 presents patient demographics and clinical findings (Table 1).

Table 1

The demographic and clinical characteristics of the patients

 

Without

Diabetic Retinopathy (n = 40)

With

Diabetic Retinopathy

(n = 94)

Total

)n = 134)

p-value

Sex

     

0.69¤

Female

24(31.2)

53 (68.8)

77(100)

Male

16(28.1)

41(71.9)

57(100)

Age (years)

     

0.18

Mean ± SD

62.47 ± 8.36

60.42 ± 7.93

61.03 ± 8.08

Median [min,max]

48[23,65]

46[29,62]

60[43,95]

Duration of disease (years)

     

0.65

Mean ± SD

9.35 ± 4.34

9.75 ± 4.93

9.63 ± 4.75

Median [min,max]

13[7,32]

11.5 [7,24]

10 [7,32]

NPDR

     

-

Mild to Moderate

 

26(100)

26(100)

Severe

 

28(100)

28(100)

PDR

     

-

Early

 

21(100)

21(100)

High risk

 

19(100)

19(100)

¤: Resulted from chi-square test

¶: Resulted from independent t-test

Comparison of the corneal parameters between the patients with and without DR are shown in Table 2 (Table 2). The overall corneal parameters in diabetic patients with and without retinopathy were not significantly different between the two groups (P > 0.05). In addition, age-wise stratification of the subjects had not shown a significant difference between the two groups (Table 2).

Table 2

Age-wise comparison of outcome measures in patients with and without diabetic retinopathy

 

Age group (years)

Without

Diabetic Retinopathy

With

Diabetic Retinopathy

p-value

Endothelial Cell Density

(cell/mm2)

≤ 55

2461.22 ± 157.5

2437.92 ± 530.29

0.99©

2501 [2190, 2665]

2431 [224, 3148]

55–60

2483.5 ± 47.38

2612.71 ± 617.6

0.770

2483.5 [2450, 2517]

2666 [531, 3564]

60–65

2671.25 ± 311.61

2544 ± 265.8

0.202

2527.5 [2325, 3354]

2543 [2001, 3037]

≥ 65

2522.8 ± 317.92

2604.58 ± 281.20

0.382

2460 [2138, 3353]

2639.5 [1944, 3015]

All age

2551.5 ± 284.41

2544.97 ± 428.20

0.328©

2500.5 [2138, 3354]

2582.5 [224, 3564]

Average cell size

≤ 55

408.3 ± 27.17

401.08 ± 39

0.610

400 [375, 457]

411 [318, 451]

55–60

402.5 ± 7.78

459.12 ± 369.31

0.143©

402.5 [397, 408]

375 [281, 1883]

60–65

378.3 ± 40.80

391.19 ± 48.40

0.430

396 [298, 430]

389.5 [294, 500]

≥ 65

398.94 ± 46.3

388.73 ± 47.03

0.488

379 [332, 514]

379 [332, 514]

All age

395.05 ± 40.47

405.43 ± 160.46

0.313©

399.5 [298, 468]

387 [281, 1883]

Coefficient of variation

≤ 55

40.89 ± 7.97

40.96 ± 7.66

0.981

44 [27, 52]

40 [30, 60]

55–60

45.5 ± 7.78

42.41 ± 6.31

0.527

45.5 [40, 51]

44 [32, 51]

60–65

40.5 ± 7.56

45.61 ± 8.17

0.075

40 [32, 62]

44 [34, 65]

≥ 65

46.53 ± 4.68

43.07 ± 7.11

0.085

48 [35, 52]

42 [33, 68]

All age

43.4 ± 6.94

43.09 ± 7.52

0.827

43.5 [27, 62]

43 [30, 68]

Hexagonality (%)

≤ 55

50.66 ± 9.06

46.8 ± 6.46

0.177

50 [39, 65]

47 [33, 66]

55–60

45.5 ± 6.36

45.12 ± 7.75

0.948

45.5 [41, 50]

45 [30, 61]

60–65

49.83 ± 9.98

46.46 ± 10.45

0.355

45.5 [41, 77]

45.5 [29, 80]

≥ 65

46.88 ± 11.48

46.19 ± 8.38

0.821

48 [23, 67]

47.5 [29, 66]

All age

48.55 ± 10.16

46.23 ± 8.34

0.217©

47.5 [23, 77]

46 [29, 80]

: Resulted from Independent T Test

©:Resulted from Mann U Witny Test

A comparison of the corneal parameters according to DR classification is shown in Table 3 (Table 3). In the 60–65 years’ age groups, statistically increased CV was seen with increasing the severity of DR. Mean CV were 40.5 ± 7.56, 43.56 ± 8.60, and 48.9 ± 6.54 in the patients without DR, NPDR, and PDR, respectively. The differences in CV between the groups were marginally significant (P = 0.052) (Table 3).

Table 3

Age-wise comparison of outcome measures in patients without DR, NPDR and PDR

 

Age group (years)

Without DR

NPDR

PDR

p-value

Endothelial cell density

(cell/mm2)

≤ 55

2461.22 ± 157.5

2395.64 ± 685.96

2491.72 ± 239.81

0.873

2501 [2190, 2665]

2431 [224, 3148]

2404 [2217, 2920]

55–60

2483.5 ± 47.37

2512.5 ± 714.28

2853.2 ± 142.28

0.552

2483.5 [2450, 2517]

2613 [531, 3564]

2834 [2665, 2998]

60–65

2671.25 ± 311.62

2565.87 ± 277.8

2509 ± 255.85

0.396

2527.5 [2325, 3354]

2543 [2168, 3037]

2563 [2001, 2892]

≥ 65

2522.88 ± 317.93

2677.42 ± 212.40

2542.14 ± 323.72

0.351

2460 [2138, 3353]

2693 [2164, 3015]

2585.5 [1944, 2944]

All age

2551.51 ± 284.4

2534.66 ± 512.47

2558.87 ± 282.80

0.954

2500.5 [2138, 3354]

2582.5 [224, 3564]

2568.5 [1944, 2998]

Average cell size

≤ 55

408.33 ± 27.17

398.43 ± 41.88

404.45 ± 36.73

0.812

400 [375, 457]

410 [318, 450]

416 [342, 451]

55–60

402.5 ± 7.78

504.08 ± 436.78

351.2 ± 17.60

0.057©

402.5 [397, 408]

382.5 [281, 1883]

353.0 [334, 375]

60–65

378.33 ± 40.79

386.63 ± 49.76

398.5 ± 47.76

0.603

396 [298, 430]

387 [294, 461]

390 [320, 500]

≥ 65

398.94 ± 46.30

375.75 ± 32.49

399.86 ± 55.42

0.335

400 [298, 468]

371 [332, 462]

386.5 [340, 514]

All age

395.05 ± 40.47

413.37 ± 208.33

394.7 ± 47.02

0.430©

399.5 [298, 468]

387 [281, 1883]

389 [320, 514]

Coefficient of variation

≤ 55

40.88 ± 7.97

40.71 ± 8.31

41.28 ± 7.05

0.984

44 [27, 52]

38 [30, 60]

42 [31, 53]

55–60

45.5 ± 7.78

43.17 ± 5.83

40.6 ± 7.73

0.628

45.5 [40, 51]

44 [32, 51]

38 [32, 51]

60–65

40.5 ± 7.56

43.56 ± 8.60

48.9 ± 6.54

0.052

40 [32, 62]

43 [34, 65]

47.5 [40, 61]

≥ 65

46.53 ± 4.67

43 ± 5.08

43.14 ± 8.68

0.231

48 [35, 52]

43 [34, 51]

41.5 [33, 68]

All age

43.4 ± 6.94

42.6 ± 7.519

43.7 ± 7.98

0.745

43.5 [27, 62]

43 [30, 65]

43.5 [31, 68]

Hexagonality (%)

≤ 55

50.66 ± 9.06

46.78 ± 5.52

49.27 ± 13.72

0.408

50 [39, 65]

47.5 [30, 59]

49 [32, 80]

55–60

45.50 ± 6.36

44.16 ± 6.64

47.4 ± 10.45

0.739

45.5 [41, 50]

44 [30, 57]

49 [32, 61]

60–65

49.83 ± 9.98

47.25 ± 6.96

45.2 ± 14.83

0.583

45.5 [41, 77]

46 [35, 59]

40 [29, 80]

≥ 65

46.88 ± 11.48

46.75 ± 6.01

45.71 ± 10.19

0.941

48 [23, 67]

46.5 [37, 61]

49 [29, 66]

All age

48.55 ± 10.16

46.33 ± 6.26

46.1 ± 10.62

0.742©

47.5 [23, 77]

46 [30, 61]

46.5 [29, 80]

: Resulted from one way onova

©:Resulted from Kruskal–Wallis

Using a partial correlation coefficient, the relationship between corneal endothelial parameters and the duration of diabetes disease was investigated. There is a significant relationship between CV and the duration of the disease with age variable control (correlation = 0.326, p-value < 0.001) (Table 4).

Table 4

Partial correlation coefficients controlling for age

Adjusted Age

Endothelial cell density

(cell/mm2)

Cell size

Coefficient Of variation

Hexagonality (%)

Duration disease

0.026

0.125

0.326

-0.053

p- value

0.769

0.153

< 0.001

0.543

Discussion:

The result of our study demonstrated that in diabetic patients without and with DR, corneal endothelial parameters were not statistically significant difference. There was a significant relationship between CV and the duration of the disease with age variable control.

The cornea with altered morphology and functionality is known to be more susceptible to pathologies like recurrent corneal erosions, and impaired corneal sensitivity following trauma or surgical insult leading to recurrent ulceration with impaired healing (1, 2, 15). So recognition of any potential endothelial dysfunction before the surgery potentially can be associated with more positive surgical outcomes (16). Corneal endothelial cell parameters can be helpful indexes before referring patients for cataract or refractive surgery (9, 16).

The possible explanation for corneal endothelial changes in DM patients is multifactorial including impairment of apical junctions on the endothelial cells, impairment of physical barriers of corneal cell and altered permeability of corneal cell due to reduced Na+/K + ATPase activity pump in the endothelial cells (17, 18) Diabetic cornea especially with high glucose can lead cellular swelling due to increased sorbitol inside the cells due to increased activity of aldose reductase (17, 19).

Having exact data about the number and morphology of endothelial cells before cataract surgery reduces the risk of endothelial injury, especially in patients with DM (10). In contrast to our study, limited studies have addressed the association of the severity of DR with the altered corneal endothelial parameters (11, 12).

A recent study by Ashok Jha et al. demonstrated DM patients had significantly an altered morphology including increased polymegathism, decreased cell density, and hexagonality when compared with healthy controls (11). The effect of severity of DR and corneal parameters can be indirect via the effect of factors like duration, the severity of DM, age, etc (11)

Since there was no endothelial cells proliferation with aging, on one hand, the number of corneal endothelial will be decreased and on the other hand cells size will be increased to compensate for the lack of lost cells.

In each ocular surgery, the CV number should be in the normal range to ensure that it does not occur decompensation after the ocular surgery (8, 9). In the current study, it was shown that there were no significant differences in CV number in NPDR and PDR groups.

Choo et al. in 2010, did not show any correlation to the duration of DM, hemoglobin A1c level, and severity of DR (12). In contrast to the study of Choo et al., in our study, there is a significant relationship between CV and the duration of the disease with age variable control that is a predictable and acceptable finding regarding increasing the adverse effect of DM in all organs with increasing the duration of diabetes (20). This differentiation may be due to different ethnicity between Iranian and Japanese populations and differences in duration of disease in the enrolled population.

The findings of a study of Nurdan Gamze Taşlı et.al (21) about corneal specular microscopy in patients with type-2 DM demonstrated an increase in the stage of DR, alterations in corneal findings also increased. In our study, marginally association was obtained in the 60–65 years age groups for CV.

The possible explanation for the absence of statistically significant differences between other parameters of endothelial changes and severity of DM can be attributed to a relatively small sample size of our study and may be associated with ethnic differences (21).

Although our study has a suitable data analysis regarding different age groups and different DR grades for evaluation of DR on corneal endothelial parameters effect, there is some limitation including relatively small sample size, absence of normal population group as normal control, absence of level of glycosylated hemoglobin (HbA1c) and absence of data about corneal thickness.

Conclusion:

The results of the current study demonstrated that DM has negative effects on a CV as one of the important corneal endothelium parameters. There is a significant relationship between CV and the duration of the disease with age variable control. So, the long-lasting DM may further warrant a corneal evaluation before intraocular surgery.

Abbreviations:

DR: diabetic retinopathy 

ECD: endothelial cell density 

AVG: average cell size 

CV: coefficient of variation in cell size 

Hex: hexagonality 

DM: diabetes mellitus 

ETDRS: Early Treatment Diabetic Retinopathy Study 

SD: standard deviation 

Declarations:

Ethics approval and consent to participate:

This study was performed based on ethical code obtained from Isfahan University of Medical Sciences with the number  IR.MUI.MED.REC.1399.709. Written consent was obtained from all participants in the study before enrolling in the study.

Availability of data and materials:

All data generated or analyzed during this study are included in this published article.

Competing interests: 

The authors indicate no financial conflicts of interest.

Funding:

None of the authors has any financial disclosures.

Authors' contributions:

MT and MP wrote the main manuscript text; SAAM and MT analyzed the data. SAAM, AD, MA and MM conceptualized and designed the study. MF and MM edited and reviewed the manuscript. All authors have accepted the final version of the manuscript. All authors read and approved the final manuscript.

Acknowledgements: Nil

References:

  1. Roszkowska AM, Tringali CG, Colosi P, Squeri CA, Ferreri G. Corneal endothelium evaluation in type I and type II diabetes mellitus. Ophthalmologica Journal international d'ophtalmologie International journal of ophthalmology Zeitschrift fur Augenheilkunde. 1999;213(4):258–61. Epub 1999/07/27.
  2. Shenoy R, Khandekar R, Bialasiewicz A, Al Muniri A. Corneal endothelium in patients with diabetes mellitus: a historical cohort study. European journal of ophthalmology. 2009;19(3):369–75. Epub 2009/04/28.
  3. Sudhir RR, Raman R, Sharma T. Changes in the corneal endothelial cell density and morphology in patients with type 2 diabetes mellitus: a population-based study, Sankara Nethralaya Diabetic Retinopathy and Molecular Genetics Study (SN-DREAMS, Report 23). Cornea. 2012;31(10):1119–22. Epub 2012/02/24.
  4. Sachdeva MM. Retinal Neurodegeneration in Diabetes: an Emerging Concept in Diabetic Retinopathy. Current diabetes reports. 2021;21(12):65. Epub 2021/12/14.
  5. Samanta A, Mauntana S, Barsi Z, Yarlagadda B, Nelson PC. Is your vision blurry? A systematic review of home-based visual acuity for telemedicine. Journal of telemedicine and telecare. 2020:1357633X20970398. Epub 2020/11/24.
  6. Kaji Y, Usui T, Oshika T, Matsubara M, Yamashita H, Araie M, et al. Advanced glycation end products in diabetic corneas. Investigative ophthalmology & visual science. 2000;41(2):362–8. Epub 2000/02/12.
  7. Wang Y, Zhou Q, Xie L. [Diabetic keratopathy: new progresses and challenges]. [Zhonghua yan ke za zhi] Chinese journal of ophthalmology. 2014;50(1):69–72. Epub 2014/04/09.
  8. Goldstein AS, Janson BJ, Skeie JM, Ling JJ, Greiner MA. The effects of diabetes mellitus on the corneal endothelium: A review. Survey of ophthalmology. 2020;65(4):438–50. Epub 2020/01/12.
  9. Pont C, Ascaso FJ, Grzybowski A, Huerva V. Corneal endothelial cell density during diabetes mellitus and ocular diabetes complications treatment. Journal francais d'ophtalmologie. 2020;43(8):794–8. Epub 2020/07/04.
  10. Durukan I. Corneal endothelial changes in type 2 diabetes mellitus relative to diabetic retinopathy. Clinical & experimental optometry. 2020;103(4):474–8. Epub 2019/10/17.
  11. Jha A, Verma A, Alagorie AR. Association of the severity of diabetic retinopathy with corneal endothelial and thickness changes in patients with diabetes mellitus. Eye. 2021.
  12. Choo M, Prakash K, Samsudin A, Soong T, Ramli N, Kadir A. Corneal changes in type II diabetes mellitus in Malaysia. International journal of ophthalmology. 2010;3(3):234–6. Epub 2010/01/01.
  13. Liaboe CA, Aldrich BT, Carter PC, Skeie JM, Burckart KA, Schmidt GA, et al. Assessing the Impact of Diabetes Mellitus on Donor Corneal Endothelial Cell Density. Cornea. 2017;36(5):561–6. Epub 2017/03/18.
  14. Four risk factors for severe visual loss in diabetic retinopathy. The third report from the Diabetic Retinopathy Study. The Diabetic Retinopathy Study Research Group. Archives of ophthalmology (Chicago, Ill: 1960). 1979;97(4):654-5. Epub 1979/04/01.
  15. Inoue K, Kato S, Inoue Y, Amano S, Oshika T. The corneal endothelium and thickness in type II diabetes mellitus. Japanese journal of ophthalmology. 2002;46(1):65–9. Epub 2002/02/21.
  16. Greene JB, Mian SI. Cataract surgery in patients with corneal disease. Current opinion in ophthalmology. 2013;24(1):9–14. Epub 2012/12/01.
  17. Wigham CG, Guggenheim JA, Hodson SA. Sodium movement into and out of corneal endothelium. Pflugers Archiv: European journal of physiology. 1994;428(5–6):577–82. Epub 1994/10/01.
  18. Browning D. Diabetic retinopathy: Evidence-based management2010. 1-454 p.
  19. Yanagiya N, Akiba J, Kado M, Yoshida A, Kono T, Iwamoto J. Transient corneal edema induced by nitric oxide synthase inhibition. Nitric oxide: biology and chemistry. 1997;1(5):397–403. Epub 1998/01/27.
  20. Ryan CM, Geckle MO, Orchard TJ. Cognitive efficiency declines over time in adults with Type 1 diabetes: effects of micro-and macrovascular complications. Diabetologia. 2003;46(7):940–8. Epub 2003/06/24.
  21. Taşll, N. G., Icel, E., Karakurt, Y., Ucak, T., Ugurlu, A., Yilmaz, H., & Akbas, E. M. (2020). The findings of corneal specular microscopy in patients with type-2 diabetes mellitus. BMC Ophthalmology, 20(1). https://doi.org/10.1186/s12886-020-01488-9